Company
Amyris, Inc.
Headquarters: EmeryVille, CA, United States
Founded: 2003
Employees: 980
CEO: Mr. John G. Melo
Market Cap
$18.5 Million
USD as of Oct. 1, 2023
Amyris, Inc. Categories
United States Basic Materials Specialty ChemicalsUnited States Basic Materials United States Specialty Chemicals
Top Competitors by Market Capitalization
Industry: Specialty Chemicals
| Company | Market Cap (USD) |
|---|---|
| Linde | $198.22 B |
| The Sherwin-Williams Company | $75.71 B |
| Ecolab Inc. | $55.92 B |
| Sika AG | $48.54 B |
| Givaudan SA | $37.12 B |
Sector:
| Company | Market Cap (USD) |
|---|---|
| Linde | $198.22 B |
| BHP | $169.91 B |
| Rio Tinto | $120.67 B |
| Air Liquide SA | $101.75 B |
| Shin-Etsu Chemical Co Ltd | $82.56 B |
Detailed Description
Amyris, Inc., a synthetic biotechnology company, operates in the clean health and beauty, and flavors and fragrance markets in Europe, North America, Asia, and South America. The company manufactures and sells clean beauty, personal care, and health and wellness consumer products, as well as ingredients to the flavor and fragrance, nutrition, food and beverage, and clean beauty and personal care end markets. It offers its products under the Biossance, Pipette, Purecane, Terasana, Costa Brazil, OLIKA, Rose Inc., and JVN brand names. The company has a collaboration agreement with the Infectious Disease Research Institute for the development of a COVID-19 vaccine. The company was formerly known as Amyris Biotechnologies, Inc. and changed its name to Amyris, Inc. in June 2010. Amyris, Inc. was incorporated in 2003 and is headquartered in Emeryville, California.
Top 1-year algo backtest: +269.94%
$10,000 in May 2023 would now be $36,994 by following this algorithm daily at market close.
Boost your stocks returns with Disfold AI... Now!
Try Disfold AI for FREE
Stocks & Indices
Amyris, Inc. has the following listings and related stock indices.
Stock: NASDAQ: AMRS wb_incandescent
Stock: FSX: 3A01 wb_incandescent
Key People
John G. Melo (CEO) Eduardo Alvarez (COO) Han Kieftenbeld (CFO) Nicole Kelsey (Gen. Counsel & Secretary)
Financials
Revenue: $152.6 million (FY 2019)